January 15, 2025—NextBioMedical Co., Ltd., which is based in South Korea, announced that it has received investigational device exemption (IDE) approval from the FDA for its RESORB clinical trial of ...
Open source, maximum permissive Apache 2.0 license Cross-platform IDE and Unified Debugger Static Code Analyzer and Remote Unit Testing Multi-platform and Multi-architecture Build System Firmware File ...
AndeSight™ provides the user-friendly multicore debugging feature for both SMP and AMP systems in one IDE interface. To further enhance the ultimate debugging efficiency for multiprocessors, it offers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback